S.Biomedics Co., Ltd. (KOSDAQ: 304360)
South Korea flag South Korea · Delayed Price · Currency is KRW
18,860
-950 (-4.80%)
Nov 18, 2024, 1:21 PM KST

S.Biomedics Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Market Capitalization
217,062130,376----
Upgrade
Enterprise Value
225,403133,226----
Upgrade
Last Close Price
18480.0011500.00----
Upgrade
PS Ratio
17.649.95----
Upgrade
PB Ratio
95.2910.62----
Upgrade
P/TBV Ratio
210.9519.14----
Upgrade
EV/Sales Ratio
18.9410.16----
Upgrade
Debt / Equity Ratio
1.370.9813.331.781.170.35
Upgrade
Asset Turnover
0.370.470.570.490.260.22
Upgrade
Inventory Turnover
2.393.335.146.186.075.34
Upgrade
Quick Ratio
1.031.650.753.191.962.97
Upgrade
Current Ratio
1.402.030.953.442.123.14
Upgrade
Return on Equity (ROE)
-77.31%-97.08%-195.41%-121.47%-97.95%-64.37%
Upgrade
Return on Assets (ROA)
-12.90%-13.30%-11.13%-16.13%-26.13%-25.05%
Upgrade
Return on Capital (ROIC)
-18.03%-19.15%-18.41%-27.49%-38.11%-31.69%
Upgrade
Earnings Yield
-4.65%-5.77%----
Upgrade
FCF Yield
-3.36%-6.13%----
Upgrade
Buyback Yield / Dilution
-9.52%-6.97%-0.67%-0.42%-3.93%-406.19%
Upgrade
Total Shareholder Return
-9.52%-6.97%-0.67%-0.42%-3.93%-406.19%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.